PLOOSTER MATTHEW R purchased 146.7% of their position (11K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $46.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/13/2023ACC: 0001437749-23-006280
Director
Since Apr 2019
+11K
Net shares
Net buyer
$46.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11K
Price / share
$4.20
Trade value
$46.15K
% of position
146.7%
3/9/2023
7.50K→18.50K
Total
Net shares
+11K
Net value
$46.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2023 | P · Purchase | +11K | $4.20 | $46.15K | 146.7% | 7.50K | 18.50K |
| Total | +11K | $46.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned1.53K
Common Stock
IndirectShares owned69.00
Total
1.53K direct·69.00 indirect1.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.53K | Direct |
| Common Stock | 69.00 | Indirect |
| Total | 1.60K | 1.53K direct·69.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported